MARKET

CDLX

CDLX

CARDLYTICS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

36.83
+0.73
+2.01%
Opening 09:47 09/23 EDT
OPEN
36.16
PREV CLOSE
36.10
HIGH
36.96
LOW
36.16
VOLUME
12.75K
TURNOVER
--
52 WEEK HIGH
39.62
52 WEEK LOW
9.80
MARKET CAP
910.75M
P/E (TTM)
-24.6025
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CDLX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CDLX News

  • Week 39 Breakout Forecast: Short-Term Picks To Give You An Edge
  • Seeking Alpha - Article.3h ago
  • Cardlytics to Discuss the Value of Omni Consumers and Performance Marketing at Advertising Week in New York
  • Business Wire.3d ago
  • Value Picks Crush Momentum In First Major Reversal Since 2009:  What's Next
  • Seeking Alpha - Article.6d ago
  • Cardlytics Inc (CDLX) CEO Scott D. Grimes Sold $8.1 million of Shares
  • GuruFocus.com.09/13 23:59

More

Industry

Advertising & Marketing
-0.17%
Media & Publishing
+0.18%

Hot Stocks

Name
Price
%Change

About CDLX

Cardlytics, Inc. is engaged in developing a purchase intelligence platform. The Company delivers relevant and measurable marketing analysis with purchase data from over financial institutions. The purchase data includes debit, credit, and bill pay data from online and in-store transactions. It helps the marketers identify, reach and influence likely buyers at scale, and measure the impact of marketing spends. The Company also operates an advertising channel, Cardlytics Direct. Cardlytics Direct delivers tailored marketing for marketers and financial institutions (FI). It provides personalized offers and suggestions for FI consumers on their purchase.
More

Webull offers Cardlytics Inc (CDLX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.